Innovus Pharmaceuticals Eliminates over $1.8M in Liabilities
Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company) www.innovuspharma.com (OTCQB:INNV), a company focusing on the commercialization of over-the-counter ("OTC") and consumer products for men's and women's health, vitality and respiratory diseases, announced today that the Company has reduced its debt obligation by $1.5 million and also eliminated approximately $300k in derivative liabilities as of 3/31/16, resulting in a total reduction of outstanding liabilities of over $1.8 million.
View full press release